People with heart disease may receive different care because of how race is interpreted in health risk calculators and other tools that help clinicians make treatment decisions.
M&A activity in the pharmaceutical industry in Sweden increased in 2024
In value terms, M&A activity in Sweden remained flat in Q1 2024 compared with the previous quarter and as compared to Q1 2023. Related deal